Effects of aldose reductase inhibitor on the peripheral nerve function during ischemia in diabetics
- PMID: 3110345
Effects of aldose reductase inhibitor on the peripheral nerve function during ischemia in diabetics
Similar articles
-
Effects of a new aldose reductase inhibitor on various tissues in vitro.J Pharmacol Exp Ther. 1984 Apr;229(1):226-30. J Pharmacol Exp Ther. 1984. PMID: 6423811
-
[Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].No To Shinkei. 1998 Sep;50(9):817-20. No To Shinkei. 1998. PMID: 9789304 Japanese.
-
Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.J Pharmacol Exp Ther. 1990 May;253(2):552-7. J Pharmacol Exp Ther. 1990. PMID: 2159998
-
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.J Diabetes Complications. 2010 Sep-Oct;24(5):354-60. doi: 10.1016/j.jdiacomp.2009.07.005. Epub 2009 Sep 11. J Diabetes Complications. 2010. PMID: 19748287 Review.
-
Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.Pharmacotherapy. 2008 May;28(5):646-55. doi: 10.1592/phco.28.5.646. Pharmacotherapy. 2008. PMID: 18447661 Review.
Cited by
-
Epalrestat Stimulated Oxidative Stress, Inflammation, and Fibrogenesis in Mouse Liver.Toxicol Sci. 2018 Jun 1;163(2):397-408. doi: 10.1093/toxsci/kfx038. Toxicol Sci. 2018. PMID: 28204799 Free PMC article.
-
Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.Drugs Aging. 1993 Nov-Dec;3(6):532-55. doi: 10.2165/00002512-199303060-00007. Drugs Aging. 1993. PMID: 8312678 Review.
MeSH terms
Substances
LinkOut - more resources
Medical